Skip to main content

Advertisement

Open Peer Review Reports for: Denosumab versus zoledronic acid for preventing symptomatic skeletal events in Asian postmenopausal women with oestrogen-receptor-positive advanced breast cancer: an outcome analyses with a mean follow-up of 3 years

Back to article

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
3 Jul 2017 Submitted Original manuscript
2 Oct 2017 Reviewed Reviewer Report - John Hilton
11 Dec 2017 Reviewed Reviewer Report - Monica N. Fornier
4 Feb 2018 Author responded Author comments - Jie Ma
Resubmission - Version 2
4 Feb 2018 Submitted Manuscript version 2
27 Mar 2018 Reviewed Reviewer Report - John Hilton
21 Apr 2018 Author responded Author comments - Chi Zhang
Resubmission - Version 3
21 Apr 2018 Submitted Manuscript version 3
20 Jul 2018 Reviewed Reviewer Report - Christina Addison
2 Nov 2018 Author responded Author comments - Chi Zhang
Resubmission - Version 4
2 Nov 2018 Submitted Manuscript version 4
6 Nov 2018 Author responded Author comments - Chi Zhang
Resubmission - Version 5
6 Nov 2018 Submitted Manuscript version 5
Publishing
12 Nov 2018 Editorially accepted
30 Nov 2018 Article published 10.1186/s12891-018-2338-6

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement